GSK2578215A is a potent leucine-rich repeat kinase 2 (LRRK2) inhibitor (IC50 values are 8.9 and 10.1 nM respectively for LRRK2[G2019S] mutant and wild-type LRRK2 respectively).
More Information Supplier PageMiglustat hydrochloride is an orally active ??-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor.
More Information Supplier PageMiglustat hydrochloride is an orally active ??-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor.
More Information Supplier PageMiglustat hydrochloride is an orally active ??-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor.
More Information Supplier PageMiglustat hydrochloride is an orally active ??-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor.
More Information Supplier PageTrimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.
More Information Supplier PageTrimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.
More Information Supplier PageTrimetrexate is a quinazoline derivative. It is a dihydrofolate reductase inhibitor.
More Information Supplier PageGSK2578215A is a potent leucine-rich repeat kinase 2 (LRRK2) inhibitor (IC50 values are 8.9 and 10.1 nM respectively for LRRK2[G2019S] mutant and wild-type LRRK2 respectively).
More Information Supplier PageGSK2578215A is a potent leucine-rich repeat kinase 2 (LRRK2) inhibitor (IC50 values are 8.9 and 10.1 nM respectively for LRRK2[G2019S] mutant and wild-type LRRK2 respectively).
More Information Supplier Page
